The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Combodart 0.5 mg/ 0.4 mg hard capsules

0.5 mg/0.4 milligram(s) Capsule, hard

GlaxoSmithKline (Ireland) LimitedPA1077/118/001

Main Information

Trade NameCombodart 0.5 mg/ 0.4 mg hard capsules
Active SubstancesDutasteride
Tamsulosin hydrochloride
Strength0.5 mg/0.4 milligram(s)
Dosage FormCapsule, hard
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/118/001

Group Information

ATC CodeG04CA Alpha-adrenoreceptor antagonists
G04CA52 tamsulosin and dutasteride

Status

Authorised/WithdrawnAuthorised
Licence Issued07/05/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0036-065-001
Interchangeable List DocumentPDF of Interchangeable List
« Back